Meeting
2018 ASCO Annual Meeting
P3BEP (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours (GCTs).
Authors
Peter S. Grimison
Chris O'Brien Lifehouse, Sydney, Australia
Peter S. Grimison , Nicola Jane Lawrence , Martin R. Stockler , Andrew James Martin , Sonia Yip , Nicole Wong , Annie Yeung , Michael Friedlander , Danish Mazhar , Farzana Pashankar , David I. Quinn , Ray McDermott , Rick Walker , Mark Winstanley , Fritha J. Hanning , Andrew James Weickhardt , Amanda Gwendolyn Stevanovic , Ian D. Davis , Guy C. Toner
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Nonprostate) Cancer
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Germ Cell/Testicular
Clinical Trial Registration Number
NCT02582697
Citation
J Clin Oncol 36, 2018 (suppl; abstr TPS4596)
DOI
10.1200/JCO.2018.36.15_suppl.TPS4596
Abstract #
TPS4596
Poster Bd #
417a
Abstract Disclosures
Similar Posters
Poster
2018 Genitourinary Cancers Symposium
P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumors (GCTs).
First Author: Namrata Nayar
Poster
2017 ASCO Annual Meeting
P3BEP (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours (GCTs).
First Author: Peter S. Grimison
Poster
2019 Genitourinary Cancers Symposium
P3BEP (ANZUP 1302): An international randomized phase III trial of accelerated versus standard BEP chemotherapy for adult and pediatric male and female patients with intermediate and poor-risk metastatic germ cell tumors (GCTs).
First Author: Alison Yan Zhang
Poster
2023 ASCO Genitourinary Cancers Symposium
P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate- and poor-risk metastatic germ cell tumours (GCTs).
First Author: Danka Zebic